The ESCCA Conferences have become of major importance for education and scientific exchange in the fields of basic, translational and clinical applications in cytometry, in particular, flow cytometry applications and in Hematology, Immunology, Cancer and Cell Biology.
Due to the COVID-19 pandemic, the 2020 Conference has been postponed to 21-24 April 2021.
Accreditation by the European Accreditation Council for Continuing Medical Education (EACCME) will be applied for.
The programme will include plenary sessions, parallel sessions streams in the fields of Hematology-Oncology, Data analysis and Immunology, and parallel oral & poster presentations sessions. In addition there will be time to view e-posters during the breaks.
The preliminary programme at a glance can be downloaded here.
The preliminary full programme will be available by July 2020.
Antigen-specific immunity: In the wake of huge immunotherapeutic successes in many areas of medicine, particularly cancer, ESCCA has developed a new, dedicated guest track that will reflect the latest developments in this new exciting area with a particular focus on the application and monitoring of immunotherapies. The new parallel programme track will be closely coordinated with all relevant immunological and clinical topics.
Data analysis: from general principles of flow data representation/analysis to data handling and repositories, from data preparation to high-dimensional data analysis and large cohort – aspects we need to know about modern data analysis.
Six pre-conference training courses will be scheduled on Wednesday 21 April from 09.00-12.30 hrs. These will be available to a limited number of participants per course; pre-registration is required.
More information will be available soon.
ESCCA members will be able to take the official ESCCA European Cytometry Certification Examination during the Conference on Wednesday 21 April 2021. For general information about the Exam and how to register, please consult the Membership section of the ESCCA website.